Skip to content

Dr. Hanne Leben

Active
Private limited companyfounded 2025active for 1 yearOude-Maasstraat 5, 3500 Hasselt, BelgiumKBO/BCE: BE 1021.179.574
Summary

Dr. Hanne Leben has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €27,420 and a net result of €24,420. Its solvency ranks better than 52% of 20,614 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€41,968total assets 2025
Equity
€27,420
Profit
€24,420
Turnover not published (micro format)
Financial health
96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 2 days early
Why 96lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.88, cash €29,331Figures for financial year 2025 (filed 29-07-2026)Equity €27,420 (65.3% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 67% of its sector peers (NACE 86, micro)
Financial strength
Strong
Solvency 90
equity 65.3% of total assets
Liquidity 85
short-term debt 34.7% · cash 69.9%
Profitability 100
return on assets 58.2%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 04-2026: 0.3% 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026highest value 08-2026: < 0.1%▼ -0.3 percentage points vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €2,500 on 30-day terms is acceptable
Liquidity ample (current ratio 2.88, above the usual 1.5; short-term debt: 34.7% and cash: 69.9% of total assets), and 34.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 53% on solvency, 67% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.88, cash €29,331
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 29-07-2026)
NBB · annual accounts
lowers risk · Equity €27,420 (65.3% of total assets)
NBB · annual accounts
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 1 year 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
2 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2025.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. IncorporationAppointment: LEBEN Hanne Emma Leona…

Key points

  • One director decidessole director in office 1 View
  • Total assets 2025first financial year filed €41,968 View
  • Active since 2025founded 18-03-2025 1 years View

By topic

Financials

Financial year
2025
Total assets
€41,968
Profit
€24,420
Solvency
65.3%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
18-03-2025
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
31
Annual meeting
Last Friday of June at 19:00
Statutory auditor
No statutory auditor
Go to Articles of association

Key facts about Dr. Hanne Leben

What is the company number of Dr. Hanne Leben?
1021.179.574. In Belgium the VAT number is the company number with BE in front: BE 1021.179.574.
Where is Dr. Hanne Leben based?
The registered office is at Oude-Maasstraat 5, 3500 Hasselt.Company details
What does Dr. Hanne Leben do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Hanne Leben?
Private limited company (BV).
When was Dr. Hanne Leben founded?
On 18-03-2025.
Is Dr. Hanne Leben still active?
Yes, Dr. Hanne Leben is an active enterprise in the KBO register.
What is the turnover of Dr. Hanne Leben?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Dr. Hanne Leben profitable?
In financial year 2025, Dr. Hanne Leben made a profit of €24,420.
Where can I find the annual accounts of Dr. Hanne Leben?
Dr. Hanne Leben filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Companies related to Dr. Hanne Leben

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.